|
Volumn 5, Issue 1, 2011, Pages 60-61
|
Improving chemotherapy for patients with advanced non-small cell lung cancer.
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
NORWAY;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL RATE;
TIME;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
HUMANS;
LUNG NEOPLASMS;
NORWAY;
QUALITY OF LIFE;
SURVIVAL RATE;
TIME FACTORS;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 79954998839
PISSN: None
EISSN: 1752699X
Source Type: Journal
DOI: 10.1111/j.1752-699x.2010.00199.x Document Type: Article |
Times cited : (4)
|
References (0)
|